Publicaciones (119) Publicaciones en las que ha participado algún/a investigador/a

2022

  1. 5-Nitroindazole-based compounds: further studies for activity optimization as anti-Trypanosoma cruzi agents

    Acta Tropica, Vol. 234

  2. A High Prevalence of Cardiopulmonary Worms Detected in the Iberian Wolf (Canis lupus): A Threat for Wild and Domestic Canids

    Animals, Vol. 12, Núm. 17

  3. A Smartphone-Based Platform Assisted by Artificial Intelligence for Reading and Reporting Rapid Diagnostic Tests: Evaluation Study in SARS-CoV-2 Lateral Flow Immunoassays

    JMIR public health and surveillance, Vol. 8, Núm. 12, pp. e38533

  4. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 455-467

  5. ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation

    International Journal of Gynecological Cancer, Vol. 32, Núm. 9, pp. 1196-1200

  6. Abiotrophia spp. and Granulicatella spp. Infective Endocarditis: A Contemporary Perspective

    Frontiers in bioscience (Elite edition), Vol. 14, Núm. 3, pp. 23

  7. Actions and attitudes on the immunized patients against SARS-CoV-2

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 1, pp. 7-15

  8. Air pollution and health prevention: A document of reflection

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 307-332

  9. Amplification-free detection of SARS-CoV-2 using gold nanotriangles functionalized with oligonucleotides

    Microchimica Acta, Vol. 189, Núm. 4

  10. Antibacterial spectrum of cefiderocol

    Revista Espanola de Quimioterapia, Vol. 35, pp. 20-27

  11. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  12. Association between anti-Anisakis simplex antibodies and interleukin-7 levels

    International Immunopharmacology, Vol. 111

  13. Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283

  14. Booster or additional vaccination doses in patients vaccinated against COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 35, Núm. 2, pp. 105-114

  15. CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

    Frontiers in Microbiology, Vol. 13

  16. CASCADE: Naked eye-detection of SARS-CoV-2 using Cas13a and gold nanoparticles

    Analytica Chimica Acta, Vol. 1205

  17. COVID in Pediatric Age: an opinion paper

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 333-343

  18. COVID-19: Some unresolved issues

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 5, pp. 421-434

  19. CRISPR-Cas9 approach confirms Calcineurinresponsive zinc finger 1 (Crz1) transcription factor as a promising therapeutic target in echinocandin-resistant Candida glabrata

    PLoS ONE, Vol. 17, Núm. 3 March

  20. Can urine studies be replaced by serum free light chains measurements to assign responses in multiple myeloma patients?

    Frontiers in Oncology, Vol. 12